CFO of PURE Bioscience (PURE, Financial) Andrew J Buckland sells 100,000 shares of PURE on 06/30/2010 at an average price of $2.67 a share.
Pure Bioscience has a market cap of $83.3 million; its shares were traded at around $2.39 with and P/S ratio of 174.2.
Pure Bioscience has a market cap of $83.3 million; its shares were traded at around $2.39 with and P/S ratio of 174.2.
Directors and Officers Recent Trades:
- Buy: Director Gregory Hurd Barnhill bought 5,000 shares of PURE stock on 04/14/2010 at the average price of 2.72. Gregory Hurd Barnhill owns at least 540,044 shares after this. The price of the stock has decreased by 12.13% since.
- Buy: Director Gregory Hurd Barnhill bought 10,000 shares of PURE stock on 03/15/2010 at the average price of 1.8. Gregory Hurd Barnhill owns at least 525,044 shares after this. The price of the stock has increased by 32.78% since.
- Buy: Director John J Carbone bought 17,350 shares of PURE stock on 01/29/2010 at the average price of 1.34. John J Carbone owns at least 39,050 shares after this. The price of the stock has increased by 78.36% since.
- Sell: Director Gregory Hurd Barnhill sold 68,492 shares of PURE stock on 01/27/2010 at the average price of 1.36. Gregory Hurd Barnhill owns at least 515,044 shares after this. The price of the stock has increased by 75.74% since.
- Sell: Director Gregory Hurd Barnhill sold 60,000 shares of PURE stock on 01/21/2010 at the average price of 1.49. Gregory Hurd Barnhill owns at least 583,536 shares after this. The price of the stock has increased by 60.4% since.
